CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

ENZON PHARMACEUTICALS, INC.

ENZN
$82M
Micro Cap
NASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaCRANFORD

Enzon Pharmaceuticals, Inc. is a pharmaceutical company. Its headquarters is in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

ENZN News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How ENZN's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is ENZON PHARMACEUTICALS, INC.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for ENZON PHARMACEUTICALS, INC. (ENZN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track ENZN biotech catalysts?

Add ENZN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ENZON PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply